Sapien 3 TAVR On Par with Surgery at 5 Years

(MedPage Today) — Transcatheter aortic valve replacement (TAVR) with the contemporary Sapien 3 device generally held up against surgery in intermediate-risk patients over 5 years, according to a propensity-matched analysis.
Except for differences…
Read More

Leave a Reply

%d bloggers like this: